Gerold Morsch

Title: Gerold Morsch: Innovator in Extracorporeal Treatment Technologies

Introduction

Gerold Morsch is a notable inventor based in Willinghausen, Germany. He has made significant contributions to the field of medical technology, particularly in the area of extracorporeal treatment systems. With a total of three patents to his name, Morsch has focused on innovative processes that enhance the removal of harmful substances from blood and plasma.

Latest Patents

Morsch's latest patents include a process for simultaneously removing tumor necrosis factor alpha (TNF.alpha.) and bacterial lipopolysaccharides (LPS) from aqueous liquids, especially blood, blood plasma, or serum. This process involves adjusting the pH of the body fluid, adding a precipitation reagent, and subsequently removing precipitated substances through filtration or centrifugation. Another patent details a device designed for the extracorporeal elimination of TNF.alpha. and LPS from whole blood or blood plasma, utilizing both cation and anion exchanger materials within an extracorporeal perfusion system.

Career Highlights

Gerold Morsch is associated with B. Braun Melsungen AG, a leading company in the medical technology sector. His work has been instrumental in developing advanced treatment methods that improve patient outcomes. Morsch's innovative approaches have positioned him as a key figure in the field of extracorporeal therapies.

Collaborations

Morsch has collaborated with notable colleagues such as Karl-Siegfried Boos and Dietrich Seidel. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Gerold Morsch's contributions to medical technology through his patents and collaborations highlight his commitment to improving healthcare solutions. His innovative processes and devices continue to pave the way for advancements in extracorporeal treatment systems.